Mikanis 500mg Injection
Marketer
Insinius Pharmaceuticals
Salt Composition
Amikacin (500mg)
Overview Mikanis 500mg Injection
Cefamikan 500mg Injection, an antibiotic medication, combats a broad spectrum of bacterial infections. These infections can affect various parts of the body, including the urinary system, skeletal system, respiratory system (such as pneumonia), central nervous system, and circulatory system. Prophylactic use is also common in hospitalized individuals to prevent infections. Cefamikan 500mg Injection's mechanism involves inhibiting bacterial proliferation. Administration, strictly under medical supervision, is via intravenous infusion or intramuscular injection. Self-administration is strictly prohibited. Adherence to the prescribed dosage schedule is crucial; consistent, evenly spaced intervals are essential. Complete the entire course, even with symptom improvement, to prevent relapse. Premature cessation may result in infection recurrence or exacerbation. Common adverse effects include injection site inflammation and elevated blood urea nitrogen levels. Persistent side effects or treatment inefficacy warrant immediate medical consultation. High-dose therapy may rarely cause vertigo, nephrotoxicity, and ototoxicity. Consequently, diligent adherence to physician instructions is paramount. Regular kidney function, hearing, and urinalysis are often monitored. This medication is contraindicated during pregnancy. Disclose pregnancy, pregnancy planning, or breastfeeding to your physician.
Primary Ingredients of Mikanis 500mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Mikanis 500mg Injection
Infections caused by bacteria
Major Benefits of Mikanis 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mikanis 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikanis 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Mikanis 500mg Injection works:
Mikanis 500mg injectable solution is a bacterial growth inhibitor. Its mechanism of action involves disrupting the production of crucial bacterial proteins, thereby hindering essential cellular processes.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Mikanis 500mg Injection and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Mikanis 500mg Injection to pregnant individuals is contraindicated due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician might consider its use only when potential benefits outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Mikanis, at a 500mg dose, is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Administering Mikanis 500mg Injection could induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving is strongly discouraged if these effects manifest.
KidneyCAUTION
Administering Mikanis 500mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification for Mikanis 500mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Mikanis 500mg Injection appears to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification of Mikanis 500mg Injection may be unnecessary in this population; however, medical advice is recommended.
What if you forget to take Mikanis 500mg Injection :
Should you forget a scheduled dose of Mikanis 500mg Injection, seek advice from your physician.
Facts to Know About Mikanis 500mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action class | Aminoglycoside antibiotics |
3,018 People bought this recently